Feasibility of preoperative combined radiation therapy and chemotherapy with 5-fluorouracil and cisplatin in potentially resectable pancreatic adenocarcinoma: The French SFRO-FFCD 97-04 Phase II trial.

[1]  N. Girard,et al.  Radiochemotherapy in the management of pancreatic cancer--part I: neoadjuvant treatment. , 2005, Seminars in radiation oncology.

[2]  G. Monges,et al.  Assessment of pathologic response after preoperative chemoradiotherapy and surgery in pancreatic adenocarcinoma. , 2004, International journal of radiation oncology, biology, physics.

[3]  C. N. Coleman,et al.  CTCAE v3.0: development of a comprehensive grading system for the adverse effects of cancer treatment. , 2003, Seminars in radiation oncology.

[4]  Jeffrey E. Lee,et al.  Preoperative paclitaxel and concurrent rapid-fractionation radiation for resectable pancreatic adenocarcinoma: toxicities, histologic response rates, and event-free outcome. , 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[5]  Douglas B. Evans,et al.  Localized adenocarcinoma of the pancreas: the rationale for preoperative chemoradiation. , 2002, The oncologist.

[6]  C. Balch,et al.  AJCC Cancer Staging Manual. 6th ed , 2002 .

[7]  C. Compton,et al.  AJCC Cancer Staging Manual , 2002, Springer New York.

[8]  E. Paulson,et al.  Neoadjuvant Chemoradiation for Localized Adenocarcinoma of the Pancreas , 2001, Annals of Surgical Oncology.

[9]  B. Eisenberg,et al.  Effect of preoperative chemoradiotherapy on surgical margin status of resected adenocarcinoma of the head of the pancreas , 2001, Journal of Gastrointestinal Surgery.

[10]  A. Cooperman,et al.  Survival advantage of combined chemoradiotherapy compared with resection as the initial treatment of patients with regional pancreatic carcinoma , 2000, Cancer.

[11]  J. Jeekel,et al.  Adjuvant radiotherapy and 5-fluorouracil after curative resection of cancer of the pancreas and periampullary region: phase III trial of the EORTC gastrointestinal tract cancer cooperative group. , 1999, Annals of surgery.

[12]  Jeffrey E. Lee,et al.  Rapid-fractionation preoperative chemoradiation, pancreaticoduodenectomy, and intraoperative radiation therapy for resectable pancreatic adenocarcinoma. , 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[13]  S. Lipsitz,et al.  Phase II trial of preoperative radiation therapy and chemotherapy for patients with localized, resectable adenocarcinoma of the pancreas: an Eastern Cooperative Oncology Group Study. , 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[14]  A. Cooperman,et al.  Combined modality therapy for stage II and stage III pancreatic carcinoma. , 1997, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[15]  R H Hruban,et al.  Pancreaticoduodenectomy for pancreatic adenocarcinoma: postoperative adjuvant chemoradiation improves survival. A prospective, single-institution experience. , 1997, Annals of surgery.

[16]  Jeffrey E. Lee,et al.  Preoperative and postoperative chemoradiation strategies in patients treated with pancreaticoduodenectomy for adenocarcinoma of the pancreas. , 1997, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[17]  H. Choy,et al.  Paclitaxel and concurrent radiation for locally advanced pancreatic and gastric cancer: a phase I study. , 1997, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[18]  T. Pajak,et al.  Toxicity criteria of the Radiation Therapy Oncology Group (RTOG) and the European Organization for Research and Treatment of Cancer (EORTC) , 1995, International journal of radiation oncology, biology, physics.

[19]  J. Neoptolemos,et al.  Treatment and survival in 13560 patients with pancreatic cancer, and incidence of the disease, in the West Midlands: An epidemiological study , 1995, The British journal of surgery.

[20]  T. Inoue,et al.  Is the long-term survival rate improved by preoperative irradiation prior to Whipple's procedure for adenocarcinoma of the pancreatic head? , 1994, Archives of surgery.

[21]  B. Eisenberg,et al.  Neoadjuvant chemoradiation in pancreatic and duodenal carcinoma. A phase II study , 1993, Cancer.

[22]  F. Ames,et al.  Preoperative chemoradiation and pancreaticoduodenectomy for adenocarcinoma of the pancreas. , 1992, Archives of surgery.

[23]  E. McFadden,et al.  Toxicity and response criteria of the Eastern Cooperative Oncology Group , 1982, American journal of clinical oncology.

[24]  R. D. Hunter,et al.  WHO Handbook for Reporting Results of Cancer Treatment , 1980 .

[25]  E. Kaplan,et al.  Nonparametric Estimation from Incomplete Observations , 1958 .